{"uid":"cap_9XId9qH3wYRo9YitBafBr","slug":"darrylbots-hail-mary-stock-screen-research-report-038a1ca2","name":"DarrylBots Hail Mary Stock Screen Research Report","description":"Darrylbots paid research: Hail Mary Stock Screen: Catalyst-Defined Speculation","url":"https://darrylbots.com/api/research-report-hail-mary","method":"GET","headers":{},"bodySchema":{"type":"object","properties":{"properties":{"type":"string"}}},"responseSchema":{"type":"json","example":{"report":{"id":"stock-screen-hail-mary-2026-06","lens":"hail_mary","price":{"amount":"0.001","network":"Base","currency":"USDC","amount_atomic":"1000","network_caip2":"eip155:8453"},"title":"Hail Mary Stock Screen: Catalyst-Defined Speculation","summary":"The Hail Mary lens deliberately stops at seven candidates. The conclusion is that weak spike names should remain cash or watchlist slots rather than being promoted to force a ten-name basket.","disclaimer":"This report is research for Darrylbots only. It is not financial, investment, tax, or legal advice and is not a recommendation to buy, sell, or hold any security. Prices can move quickly, especially in Hail Mary candidates; verify live data before acting.","full_rankings":[{"name":"Zevra Therapeutics Inc","rank":1,"risk":"Single-product and regulatory/commercial execution risk.","quote":12.55,"symbol":"ZVRA","thesis":"Highest-quality Hail Mary: revenue growth, rare-disease exclusivity, debt-free balance sheet, and visible regulatory/patent catalysts.","market_cap":"685.1M","exit_or_review":"Use shares only; define a catalyst review after EMA/patent/clinical updates."},{"name":"Stitch Fix Inc","rank":2,"risk":"YoY active-client decline and discretionary retail risk.","quote":4.23,"symbol":"SFIX","thesis":"Turnaround with no debt, positive free cash flow, large cash/investment base, and early active-client stabilization.","market_cap":"573.4M","exit_or_review":"Small starter only; add only after another quarter of client growth."},{"name":"Forward Air Corp (Delaware)","rank":3,"risk":"High leverage and customer/contract transition risk.","quote":13.58,"symbol":"FWRD","thesis":"Ugly but potentially survivable logistics turnaround with improved liquidity and EBITDA base.","market_cap":"397.5M","exit_or_review":"Only if debt/refinancing path remains credible."}]},"purchased":true}},"example":{"request":{"properties":"catalyst-driven"},"response":{"report":{"id":"stock-screen-hail-mary-2026-06","lens":"hail_mary","price":{"amount":"0.001","network":"Base","currency":"USDC","amount_atomic":"1000","network_caip2":"eip155:8453"},"title":"Hail Mary Stock Screen: Catalyst-Defined Speculation","access":"paid_research","seller":{"name":"Darrylbots LLC","pay_to":"0x0BF63F37b0f512839C001548dc66a6A99Bfc019B"},"teaser":[{"name":"Zevra Therapeutics Inc","rank":1,"risk":"Single-product and regulatory/commercial execution risk.","symbol":"ZVRA","thesis":"Highest-quality Hail Mary: revenue growth, rare-disease exclusivity, debt-free balance sheet, and visible regulatory/patent catalysts.","exit_or_review":"Use shares only; define a catalyst review after EMA/patent/clinical updates."},{"name":"Stitch Fix Inc","rank":2,"risk":"YoY active-client decline and discretionary retail risk.","symbol":"SFIX","thesis":"Turnaround with no debt, positive free cash flow, large cash/investment base, and early active-client stabilization.","exit_or_review":"Small starter only; add only after another quarter of client growth."},{"name":"Forward Air Corp (Delaware)","rank":3,"risk":"High leverage and customer/contract transition risk.","symbol":"FWRD","thesis":"Ugly but potentially survivable logistics turnaround with improved liquidity and EBITDA base.","exit_or_review":"Only if debt/refinancing path remains credible."}],"payment":{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","pay_to":"0x0BF63F37b0f512839C001548dc66a6A99Bfc019B","scheme":"exact","protocol":"x402","facilitator":"https://api.cdp.coinbase.com/platform/v2/x402"},"summary":"The Hail Mary lens deliberately stops at seven candidates. The conclusion is that weak spike names should remain cash or watchlist slots rather than being promoted to force a ten-name basket.","disclaimer":"This report is research for Darrylbots only. It is not financial, investment, tax, or legal advice and is not a recommendation to buy, sell, or hold any security. Prices can move quickly, especially in Hail Mary candidates; verify live data before acting.","teaser_url":"https://darrylbots.com/bot-articles/stock-screen-2026-06/","canonical_url":"https://darrylbots.com/api/research-report-hail-mary","full_rankings":[{"name":"Zevra Therapeutics Inc","rank":1,"risk":"Single-product and regulatory/commercial execution risk.","quote":12.55,"symbol":"ZVRA","thesis":"Highest-quality Hail Mary: revenue growth, rare-disease exclusivity, debt-free balance sheet, and visible regulatory/patent catalysts.","market_cap":"685.1M","exit_or_review":"Use shares only; define a catalyst review after EMA/patent/clinical updates."},{"name":"Stitch Fix Inc","rank":2,"risk":"YoY active-client decline and discretionary retail risk.","quote":4.23,"symbol":"SFIX","thesis":"Turnaround with no debt, positive free cash flow, large cash/investment base, and early active-client stabilization.","market_cap":"573.4M","exit_or_review":"Small starter only; add only after another quarter of client growth."},{"name":"Forward Air Corp (Delaware)","rank":3,"risk":"High leverage and customer/contract transition risk.","quote":13.58,"symbol":"FWRD","thesis":"Ugly but potentially survivable logistics turnaround with improved liquidity and EBITDA base.","market_cap":"397.5M","exit_or_review":"Only if debt/refinancing path remains credible."},{"name":"Designer Brands Inc","rank":4,"risk":"Weak comps, leverage, and consumer discretionary risk.","quote":6.91,"symbol":"DBI","thesis":"Deep-value retail turnaround: gross margin improvement, debt reduction, and low expectations.","market_cap":"333.1M","exit_or_review":"Avoid averaging down without comp-sales improvement."},{"name":"Krispy Kreme Inc","rank":5,"risk":"Revenue decline, leverage, and brand execution risk.","quote":3.99,"symbol":"DNUT","thesis":"Operational reset shows EBITDA margin improvement after McDonald's-door cleanup.","market_cap":"724.1M","exit_or_review":"Treat as a turnaround watch, not a momentum trade."},{"name":"Dave and Buster's Entertainment, Inc","rank":6,"risk":"Revenue/EBITDA decline and macro sensitivity.","quote":12.32,"symbol":"PLAY","thesis":"Beaten-down consumer discretionary with positive free cash flow and liquidity.","market_cap":"457.9M","exit_or_review":"Needs evidence that back-to-basics strategy is working."},{"name":"Humacyte Inc","rank":7,"risk":"Going-concern/dilution risk remains material even after financing.","quote":1.07,"symbol":"HUMA","thesis":"Binary biotech with positive clinical signal and regulatory path.","market_cap":"239.8M","exit_or_review":"Only acceptable as a very small, catalyst-defined speculation."}],"source_package":{"title":"Darrylbots Full-Universe Stock Screen - Final Report","filters":"At least $1M/day 5-day average dollar volume, $1 price floor, $50M market-cap floor, cannabis excluded.","universe":"NYSE, Nasdaq, TSX, and TSX Venture","as_of_local":"2026-06-15 14:34 America/Los_Angeles","source_pass":"EXA search run across 30 curated and rejected tickers, 8 results per ticker.","generated_at":"2026-06-15T21:34:59.875499+00:00"},"agent_takeaways":["Do not force ten speculative names when only seven survived the quality screen.","Each candidate needs a catalyst review rule; this is not a blind microcap basket.","The default implementation should use shares, not options, unless live liquidity and spreads are unusually compelling."]},"purchased":true}},"exampleRequest":{"properties":"catalyst-driven"},"tags":["x402"],"displayCostAmount":"0.001","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"settled","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.001/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.001","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.001","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_zEQywPlz7n-BiMt0Wu0Jr","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.001","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns a curated speculative stock screening report using the 'Hail Mary' lens, identifying high-risk, catalyst-driven equity candidates with theses, rankings, and exit criteria.","exampleAgentPrompt":"Pull up the Darryl Bots Hail Mary stock screen report — I want to see the top catalyst-driven speculative picks ranked by thesis strength, with risk notes and exit criteria for each.","exampleUseCases":null,"resultDescription":"Returns a structured JSON report with a report ID, lens label ('hail_mary'), title, summary, full ranked list of speculative stock candidates (each with symbol, name, quote, market cap, investment thesis, risk factors, and exit/review guidance), purchase status, and a legal disclaimer. Typically 7 candidates or fewer by design.","failureModes":["No properties match yields an empty or default report","Payment not processed returns 402 with payment required details","Network or upstream data unavailability returns 5xx error","Stale data if report has not been refreshed for the current period"],"whenToPreferThis":"Use this endpoint when you want a pre-screened, opinionated list of speculative/catalyst-driven equities with ranked theses rather than raw screener data. Best for users seeking a curated 'hail mary' watchlist with exit criteria already defined, not a broad market scan or fundamental analysis tool.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-14T18:40:15.870Z","isFirstParty":false}